Erlotinib Completed Phase 2 Trials for Stage IV Breast Cancer / Recurrent Breast Carcinoma Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00054132Erlotinib Hydrochloride and Bevacizumab in Treating Patients With Stage IV Breast Cancer